The Patent Trial and Appeal Board denied DCSTAR Inc.'s request for discretionary denial of LifeVac LLC’s inter partes review of DCSTAR’s patent that discloses a removal device for removing obstruction in respiratory tract and connector. The board determined that discretionary denial isn’t appropriate in this proceeding, based on the totality of the evidence and arguments presented.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.